Molecular pathogenesis of parathyroid tumours

Luigia Cinque, Flavia Pugliese, Antonio Stefano Salcuni, Alfredo Scillitani, Vito Guarnieri

Research output: Contribution to journalReview articlepeer-review


Parathyroid tumors represent an elusive endocrine neoplasia, which lead to primary hyperparathyroidism, pHPT, a common endocrine calcium disorder characterized by hypercalcemia and normal-high parathormone secretion. Parathyroid tumours are benign adenomas or multiple glands hyperplasia in the vast majority (>99% of cases), while malignant neoplasms are rare (less than 1%). Despite pHPT is a common disorder, our knowledge about the genetic predisposition and molecular pathophysiology is limited to the familial syndromic forms of parathyroid tumour, that, however, represent not more than the 10% of all the cases; instead, the pathophysiology of sporadic forms remains an open field, although data about epigenetic mechanisms or private genes have been supposed. Here we present an overview of more recent acquisitions about the genetic causes along with their molecular mechanisms of benign, but also, malignant parathyroid tumours either in sporadic and familial presentation.

Original languageEnglish
Pages (from-to)891-908
Number of pages18
JournalBest Practice and Research: Clinical Endocrinology and Metabolism
Issue number6
Publication statusPublished - Dec 1 2018


  • endocrine disease
  • parathyroid
  • primary hyperparathyroidism

ASJC Scopus subject areas

  • Endocrinology, Diabetes and Metabolism
  • Endocrinology


Dive into the research topics of 'Molecular pathogenesis of parathyroid tumours'. Together they form a unique fingerprint.

Cite this